optimal neoadjuvant and adjuvant therapy for patients with early tnbc
Published 1 year ago • 745 plays • Length 5:21Download video MP4
Download video MP3
Similar videos
-
3:09
keynote-522: neoadjuvant and adjuvant pembrolizumab for early tnbc
-
2:16
tailoring neoadjuvant and adjuvant therapy in tnbc
-
4:20
keynote 522: pembrolizumab as neoadjuvant treatment for early tnbc
-
3:12
neoadjuvant versus adjuvant therapy in tnbc
-
1:42
the case for neoadjuvant pembrolizumab in tnbc
-
1:51
optimal chemotherapy combinations in tnbc gbrca subtypes
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
6:09
adjuvant endocrine therapy for breast cancer: optimal durations and regimens
-
1:24
neoadjuvant versus adjuvant treatment chemoradiotherapy in sarcoma
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy
-
1:22
immunological signatures to predict outcomes in patients with tnbc
-
2:05
treatment advances in tnbc
-
1:46
exploratory analysis of keynote-522: efs after neoadjuvant pembro chemo vs chemo for early tnbc
-
4:24
comment: pembro plus chemo in neoadjuvant and adjuvant treatment for early triple-negative breas...
-
1:03
remaining questions on the use of neoadjuvant pembrolizumab in early tnbc following keynote-522
-
7:15
pathologic complete response rates improved with the neoadjuvant and adjuvant treatment of pembr...
-
5:53
treating early-stage tnbc
-
1:00
overcoming challenges in treating patients with triple-negative breast cancer
-
1:30
emerging immunotherapy beyond checkpoint inhibitors for tnbc